𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Burgmann posts positive results for 2002

Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
209 KB
Volume
2003
Category
Article
ISSN
1350-4789

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Novozymes results for Jan-Sep 2002
Novozymes results for Jan-Sep 2002
πŸ“‚ Article πŸ“… 2003 πŸ› Elsevier Science βš– 37 KB

Catalytica Energy Systems Inc has reported turnover of $3.369 M ($4.835 M in Jan-Sep 2001), R&D costs of $10.548 M ($11.412 M), an operating loss of $15.413 M (operating loss of $13.919 M), a net loss of $14.443 M (net loss of $12.456 M), and a loss per share of $0.82 (loss per share $0.90).There is

Favourable results for Henkel in 1Q 2002
Favourable results for Henkel in 1Q 2002
πŸ“‚ Article πŸ“… 2002 πŸ› Elsevier Science βš– 39 KB

The increase in the net loss primarily reflects clinical trial costs incurred for the company's lead product, Surfaxin, currently in three Phase III trials and one Phase II trial. Selected updates on the company's progress in 1Q 2002 are included in the report. Revenues from collaborative agreements